ARCHIVES

Existing HER2 Drugs May Help More In Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

It’s Official : PRI Wins Massive FCRF Contract ; DMS Keeps Library, Lands Computer Servicea

September 18, 1987

NIH RPG Success Rate to Fall Further

June 7, 2013